medicinal
Micron Waste Secures Key Patents As It Looks to Cannabis and Beyond
Organic waste disposal is a problem facing a wide range of industries, including food services and processing, brewing and spirits, pulp and paper, biological pharmaceuticals, and even the nascent cannabis industry. With growing government regulation of pollutants and increased corporate focus on sustainability, industries are searching for clean technology solutions to manage waste challenges. Micron […]
Why Investors Should Be Focusing on Cannabis Edibles
Cannabis edibles are rapidly taking market share from flower. While there are many startups targeting the edibles space, investors may want to consider companies that have already established a reputable brand and distribution network. These companies may be better positioned to launch edibles to existing customers while benefiting from the improved economies of scale due […]
WeedMD and BLOCKStrain Launch the Industry’s First Cannabis Validation Testing Program
VANCOUVER, Jan. 15, 2019 VANCOUVER, Jan. 15, 2019 /CNW/ – WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD”), a federally-licensed producer and distributor of medical-grade cannabis, and BLOCKSTRAIN TECHNOLOGY CORP. (the “Company” or “BLOCKStrain“) (TSXV: DNAX.V) (OTC: DNAXF) are pleased to announce that they have completed the ‘first-of-its-kind’ cannabis strain validation registration program – a testing and […]
City View Green Looks to Go Public with a Unique Approach to the Market
Canada’s cannabis industry is projected to exceed C$22.7 billion over the coming years, according to Deloitte, driven by the legalization of adult-use cannabis this year. With the legalization of edibles and other consumer products next year, the industry could see even faster growth as a greater number of consumers become interested. Investors seeking exposure may […]
FSD Pharma Announces Holdings in Cannara Biotech Inc.
Canada NewsWire TORONTO, Jan. 11, 2019 TORONTO, Jan. 11, 2019 /CNW/ – FSD Pharma (“FSD“) announced today that, in connection with the business combination (the “Business Combination“) completed on December 31, 2018 among Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) (the “Issuer“), Cannara Biotech Inc. and 11038427 Canada Inc., FSD Pharma, directly or indirectly, acquired ownership […]
Aleafia Has Buyers Lined Up as Greenhouse Goes into Production
Canada’s cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte, driven by the legalization of adult-use cannabis nationwide. With more than a hundred licensed producers in the market, investors have shifted their focus from raw production capacity to durable competitive advantages. These could come in the form of distribution […]
FSD Pharma Completes Harvest And Passes Analytical Testing Of Second Lot
Company in position for pre-sales license inspection, last step to issuance of a Sales License – CSE: HUGE OTC: FSDDF FRA: 0K9 TORONTO, January 8, 2019 /CNW/ – FSD Pharma Inc. (“FSD Pharma” or the “Company”) (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9) is pleased to announce that its wholly-owned subsidiary, FV Pharma Inc. (“FV Pharma”), a licensed […]
Aleafia-Emblem Merger Creates Canada’s Largest Network of Clinics
Canada’s cannabis industry may be rapidly growing with new initial public offerings each week, but there has also been a fair share of consolidation within the industry. Investors may want to take a closer look at industry mergers, since they have the potential to create new industry leaders overnight. These larger combined companies may be […]
Gabriella’s Kitchen Adding Seasoned Executives to Its Board
Gabriella’s Kitchen (CSE: GABY) appears to be on the leading edge to service both mainstream grocery and cannabis distribution channels with CBD infused products, as well as CBD and THC-infused edible and wellness products throughout Canada and the U.S. Positioned to be a strong player in the organic market segment of a burgeoning industry, GABY […]
Canntab & FSD Pharma Make Cannabis More Palatable for Doctors
Cannabinoids have the potential to radically transform the pharmaceutical industry. For example, new studies suggest that cannabis legalization could reduce opioid prescriptions by about six to 12 percent. The problem is that medical cannabis is very different from pharmaceutical drugs—it’s hard for physicians to prescribe treatments that lack consistency or may be metabolized differently between […]
Pascal Biosciences Provides Year-End Investor Update and Reviews Upcoming Milestones
– 2018 pipeline expansion includes lead cannabinoid-based cancer therapeutic – Clinical trial in glioblastoma to begin in 2019 VANCOUVER, British Columbia and SEATTLE, Dec. 20, 2018 (GLOBE NEWSWIRE) — Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today announced a year-end review of accomplishments during 2018 and insight into plans […]
NanoSphere Closes $1.335M First Tranche of Private Placement
DENVER–(BUSINESS WIRE)–NanoSphere Health Sciences Inc. (CSE: NSHS) (OTC: NSHSF) the biotechnology leader behind the patented NanoSphere Delivery System™, is pleased to announce a first tranche closing of its non-brokered private placement announced November 28, 2018. Pursuant to the first tranche, the company issued 4,452,254 Units at a price of $0.30 per Unit for gross proceeds […]
Sales amendment granted for Highland Grow—Amendment to License Significantly Increases Product Availability for Medical and Adult Consumer-Use Markets Toronto, Ontario (December 17th, 2018) – Biome Grow Inc. (“Biome” or the “Company”) (CSE: BIO) (Frankfurt: 6OTA) (OTC: ORTFF) is pleased to announce its Nova Scotia-based subsidiary, Highland Grow Inc. (“Highland Grow”), has received its sales authorization […]
Canntab Partners with Leading Surgeon to Conduct Pain Management Trial
The opioid industry is expected to generate nearly $20 billion in annual revenue by 2020, but the addictive nature of the drug has doctors and patients increasingly concerned. With the legalization of cannabis across Canada and many U.S. states, there’s an opportunity to replace dangerous opioids with efficacious cannabinoids to treat chronic and acute pain. […]
From The Ground Up: City View Green Is Building A Winning Cannabis Strategy Piece By Piece
The Canadian cannabis industry is ripe with targets for mergers and acquisitions. For Rob Fia, CEO of Icon Exploration (TSX-V- IEX), which is completing a reverse takeover of private company City View Green (CVG), the idea of building a state-of-the art cannabis company from the ground up offered a better value proposition. In just over […]
NanoSphere Forms Strategic Partnership to Launch Evolve Products in Mexico
VANCOUVER, British Columbia Agreement will bring the patented NanoSphere Delivery System™ to an emerging $5 billion cannabis market NanoSphere Health Sciences Inc. (CSE:NSHS) (OTC:NSHSF) (“NanoSphere” or “the Company”), the biotechnology leader behind the patented NanoSphere Delivery System™, is pleased to announce the Company has signed a Letter of Intent forming a partnership with Abba Import […]
Biome Grow Signs Massive Provincial Supply Agreement
Canada’s cannabis industry has charged forward full-steam following the legalization of recreational cannabis in October. While there was an initial flurry in provincial agreements, many licensed producers experienced a shortfall in their supply commitments. These dynamics encouraged many provinces to seek additional suppliers to help meet growing customer demand as Health Canada works through its […]
NexTech Looks to Bring Augmented Reality to Ecommerce
Ecommerce spending is projected to rise from $2.3 trillion in 2017 to $4.5 trillion by 2021, according to Statista, as consumers transition from brick-and-mortar to online shopping. While desktops still represent about 60 percent of the market, mobile ecommerce users have grown to capture about 40 percent of the market. New technologies, like augmented reality, […]
Canntab Nears Commercialization with Innovative Cannabis Tablets
The global cannabis industry is projected to reach $146.4 billion by 2025, according to Grand View Research, representing a blistering 34.6 percent compound annual growth rate. With medical and adult-use legalization across a growing number of countries, there’s an enormous opportunity for innovative companies to become established market leaders and patients to access new life-changing […]
NexTech AR Brings Augmented Reality to Cannabis
The cannabis industry is projected to surpass $75 billion by 2030, according to Cowen & Co., driven by the legalization of both medical and adult-use marijuana. While just over half of Americans have used cannabis at some point in their life, cannabis companies face an uphill battle educating those that haven’t recently tried cannabis about […]
Early Cannabis Legalization Struggles Could Yield Opportunities
Canada became the first major economy to legalize adult-use cannabis on October 17th, but cannabis stocks quickly gave up their gains leading up to the historic day. In addition to traders “selling the news” and locking in their gains, supply shortages, distribution issues, and quality concerns contributed to a major pullback in the sector. The […]
High Hampton Signs LOI to Acquire California Extracts Manufacturer
The cannabis industry is projected to reach $75 billion by 2030, according to Cowen & Co., driven by the legalization of medical and recreational cannabis across a growing number of states. According to Arcview Market Research and BDS Analytics, a large portion of that growth will come from California’s newly legalized recreational market, which the […]
– Program Developed in Lab of Renowned Cannabis Researcher Dr. Nephi Stella – Lead Candidate for Glioblastoma to Begin Clinical Testing in 2019 VANCOUVER, BRITISH COLUMBIA, and SEATTLE, WASHINGTON, October 30, 2018 – Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today announced that the Company has entered into […]
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Alan Brochstein’s 420 Investor is the go-to community for investors to learn, explore, and profit from the marijuana companies. The main goal of 420 Investor is to provide real-time, objective information about the top marijuana companies in the market in order to help investors capitalize on cannabis.
The producers of O’ Cannabiz have decades of experience producing national-profile events and creating global connections between business communities in the arts, broadcasting, media and technology. They have organized trade summit initiatives with governments around the world. And they have worked closely with sponsors in all levels of Canadian government.
Silo Pharma is a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as depression, PTSD, Parkinson’s, and other rare neurological disorders.
PotBotics is a leading data aggregation and technology company focused on the global medical cannabis market.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
